Patents by Inventor Samit Chatterjee

Samit Chatterjee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tumor and immune cell imaging based on PD-L1 expression
    Patent number: 11607466
    Abstract: The presently disclosed subject matter provides compositions, kits, and methods comprising imaging agents that can detect Programmed Death Ligand 1 (PD-L1). The presently disclosed imaging agents can be used to detect diseases and disorders, such as cancer, infection, and inflammation, in a subject.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: March 21, 2023
    Assignee: The Johns Hopkins University
    Inventors: Sridhar Nimmagadda, Martin Pomper, Samit Chatterjee, Wojciech Lesniak, Dhiraj Kumar
  • TUMOR AND IMMUNE CELL IMAGING BASED ON PD-L1 EXPRESSION
    Publication number: 20190314531
    Abstract: The presently disclosed subject matter provides compositions, kits, and methods comprising imaging agents that can detect Programmed Death Ligand 1 (PD-L1). The presently disclosed imaging agents can be used to detect diseases and disorders, such as cancer, infection, and inflammation, in a subject.
    Type: Application
    Filed: December 21, 2017
    Publication date: October 17, 2019
    Inventors: Sridhar Nimmagadda, Martin Pomper, Samit Chatterjee, Wojciech Lesniak, Dhiraj Kumar